1. Home
  2. QUIK vs MSLE Comparison

QUIK vs MSLE Comparison

Compare QUIK & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$16.51

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$7.73

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
QUIK
MSLE
Founded
1988
N/A
Country
United States
Canada
Employees
51
17
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
146.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QUIK
MSLE
Price
$16.51
$7.73
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
376.6K
52.0K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
N/A
Revenue Next Year
$16.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$5.50
52 Week High
$16.89
$13.39

Technical Indicators

Market Signals
Indicator
QUIK
MSLE
Relative Strength Index (RSI) 73.88 51.69
Support Level $5.67 $6.73
Resistance Level N/A $8.37
Average True Range (ATR) 1.24 0.75
MACD 0.35 0.14
Stochastic Oscillator 90.67 33.83

Price Performance

Historical Comparison
QUIK
MSLE

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: